CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance.
CC48 是一种新型 CB2R 激动剂/FAAH 抑制剂双效药物，可阻断胃癌进展并克服紫杉醇耐药性
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03476-7
Schirizzi Annalisa, Renna Natasha, De Leonardis Giampiero, Montanaro Rosangela, Mastropasqua Francesco, Graziano Giovanni, Riganti Chiara, Pisano Isabella, Laghezza Antonio, Abate Carmen, Stefanachi Angela, Colabufo Nicola Antonio, Caccioppoli Cristina, Bianco Giusy, Valentini Anna Maria, Armentano Raffaele, Giannelli Gianluigi, Contino Marialessandra, D'Alessandro Rosalba
